Related Experiment Video
Updated: Aug 15, 2025
08:15
Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
627
MG53: A potential therapeutic target for kidney disease
Ben Ke1, Wen Shen2, Jianling Song1
1Department of Nephrology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Pharmacology Research & Perspectives
|December 30, 2022
Summary
Mitsugumin 53 (MG53) protein aids cell survival and tissue repair, showing promise for treating kidney disease. Recombinant human MG53 (rhMG53) demonstrates significant therapeutic potential in animal models.
Area of Science:
- Biomedical science
- Cell biology
- Nephrology
Background:
- Cellular integrity is crucial for tissue regeneration and survival, particularly in kidney disease pathophysiology.
- Mitsugumin 53 (MG53), a TRIM protein, is vital for repairing cell membrane damage and enhancing tissue regeneration.
- Emerging research highlights MG53's protective role in kidney diseases.
Purpose of the Study:
- To review the role and molecular mechanisms of MG53 in kidney disease.
- To explore the therapeutic potential of recombinant human MG53 (rhMG53) for kidney disease treatment.
Main Methods:
- Literature review of studies on MG53 and kidney disease.
- Analysis of molecular mechanisms underlying MG53's function.
- Evaluation of preclinical data for rhMG53 in kidney disease models.
Main Results:
- MG53 demonstrates a significant renoprotective effect.
- rhMG53 has shown beneficial effects in various animal models of kidney disease.
- The molecular mechanisms of MG53 in kidney protection are being elucidated.
Conclusions:
- MG53 plays a critical role in maintaining kidney health.
- rhMG53 presents a promising therapeutic strategy for kidney disease.
- Further research into MG53's mechanisms may reveal novel treatment approaches for kidney ailments.
Related Concept Videos
01:28Chronic Kidney Disease III: Interprofessional Care
67
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
67
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
53
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
53
01:17Factors Affecting Renal Clearance: Renal Impairment
132
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
132
01:24Chronic Kidney Disease II: Clinical Manifestations
59
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
59
01:25Chronic Kidney Disease I: Introduction
54
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
54
01:29Acute Kidney Injury II: Pathophysiology
48
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
48